Clinical trial
Open Label Trial of Hepcortespenlisimut-L (V5) Immunotherapy for HCC
NCT02256514 is registered in ClinicalTrials.gov with Immunitor LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Label Trial of Hepcortespenlisimut-L (V5) Immunotherapy for HCC
- Lead sponsor
- Immunitor LLC
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2014
- Completion date
- December 31, 2019
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hcc, liver cirrhosis